Overexpression of FUT8 can suppress the immune response in triple-negative breast cancer by mediating the abnormal N-glycosylation of B7H3, which may account for the lack of response to anti-PD1/PDL1 immunotherapy in triple-negative breast cancer patients [35]. The gene discussed is FUT8; the disease is triple-negative breast carcinoma.